相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Predicting tumour growth and its impact on survival in gemcitabine-treated patients with advanced pancreatic cancer
Maria Garcia-Cremade et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2018)
TOPGEAR: A Randomized, Phase III Trial of Perioperative ECF Chemotherapy with or Without Preoperative Chemoradiation for Resectable Gastric Cancer: Interim Results from an International, Intergroup Trial of the AGITG, TROG, EORTC and CCTG
Trevor Leong et al.
ANNALS OF SURGICAL ONCOLOGY (2017)
Bringing Model-Based Prediction to Oncology Clinical Practice: A Review of Pharmacometrics Principles and Applications
Nuria Buil-Bruna et al.
ONCOLOGIST (2016)
Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
E. C. Smyth et al.
ANNALS OF ONCOLOGY (2016)
Dynamic monitoring of circulating tumour cells to evaluate therapeutic efficacy in advanced gastric cancer
Yilin Li et al.
BRITISH JOURNAL OF CANCER (2016)
Mechanism-based modeling of the clinical effects of bevacizumab and everolimus on vestibular schwannomas of patients with neurofibromatosis type 2
Aziz Ouerdani et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2016)
Effect of Pathologic Tumor Response and Nodal Status on Survival in the Medical Research Council Adjuvant Gastric Infusional Chemotherapy Trial
Elizabeth C. Smyth et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Early Prediction of Disease Progression in Small Cell Lung Cancer: Toward Model-Based Personalized Medicine in Oncology
Nuria Buil-Bruna et al.
CANCER RESEARCH (2015)
Population pharmacokinetic-pharmacodynamic modelling in oncology: a tool for predicting clinical response
Brendan C. Bender et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2015)
Post-therapeutic response evaluation by a combination of endoscopy and CT scan in esophagogastric adenocarcinoma after chemotherapy: better than its reputation
Susanne Blank et al.
GASTRIC CANCER (2015)
Death-associated protein-3, DAP-3, correlates with preoperative chemotherapy effectiveness and prognosis of gastric cancer patients following perioperative chemotherapy and radical gastrectomy
Y. Jia et al.
BRITISH JOURNAL OF CANCER (2014)
Prognostic value of histopathological regression in 850 neoadjuvantly treated oesophagogastric adenocarcinomas
T. Schmidt et al.
BRITISH JOURNAL OF CANCER (2014)
Interim endoscopy results during neoadjuvant therapy for gastric cancer correlate with histopathological response and prognosis
Ulrike Heger et al.
GASTRIC CANCER (2014)
Tumor Stage After Neoadjuvant Chemotherapy Determines Survival After Surgery for Adenocarcinoma of the Esophagus and Esophagogastric Junction
Andrew R. Davies et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
A phase II study of neoadjuvant combination chemotherapy with docetaxel, cisplatin, and S-1 for locally advanced resectable gastric cancer: nucleotide excision repair (NER) as potential chemoresistance marker
Masahiro Hirakawa et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2013)
Prognostic Implications of the Seventh Edition of the International Union Against Cancer Classification for Patients With Gastric Cancer: The Western Experience of Patients Treated in a Single-Center European Institution
Daniel Reim et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Endoscopic ultrasonography is useful for monitoring the tumor response of neoadjuvant chemoradiation therapy in esophageal squamous cell carcinoma
Tetsuhiro Owaki et al.
AMERICAN JOURNAL OF SURGERY (2012)
Intensity-Modulated Radiation Therapy With Concurrent Chemotherapy as Preoperative Treatment for Localized Gastric Adenocarcinoma
Twisha Chakravarty et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer
P. van Hagen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Pharmacokinetic/Pharmacodynamic Model of the Testosterone Effects of Triptorelin Administered in Sustained Release Formulations in Patients with Prostate Cancer
Elba Romero et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
Multinomial Logistic Functions in Markov Chain Models of Sleep Architecture: Internal and External Validation and Covariate Analysis
Roberto Bizzotto et al.
AAPS JOURNAL (2011)
Molecular Imaging of Proliferation and Glucose Utilization: Utility for Monitoring Response and Prognosis after Neoadjuvant Therapy in Locally Advanced Gastric Cancer
Katja Ott et al.
ANNALS OF SURGICAL ONCOLOGY (2011)
Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial
Marc Ychou et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Neoadjuvant Chemotherapy Compared With Surgery Alone for Locally Advanced Cancer of the Stomach and Cardia: European Organisation for Research and Treatment of Cancer Randomized Trial 40954
Christoph Schuhmacher et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
[18F]-Fluorodeoxyglucose-Positron Emission Tomography for the Assessment of Histopathologic Response and Prognosis After Completion of Neoadjuvant Chemotherapy in Gastric Cancer
D. Vallboehmer et al.
JOURNAL OF SURGICAL ONCOLOGY (2010)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
Phase III Comparison of Preoperative Chemotherapy Compared With Chemoradiotherapy in Patients With Locally Advanced Adenocarcinoma of the Esophagogastric Junction
Michael Stahl et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Response Evaluation by Endoscopy, Rebiopsy, and Endoscopic Ultrasound Does Not Accurately Predict Histopathologic Regression After Neoadjuvant Chemoradiation for Esophageal Cancer
Paul M. Schneider et al.
ANNALS OF SURGERY (2008)
Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer
David Cunningham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Combined GADD45A and thymidine phosphorylase expression levels predict response and survival of neoadjuvant-treated gastric cancer patients
R Napieralski et al.
CLINICAL CANCER RESEARCH (2005)
Modelling a spontaneously reported side effect by use of a Markov mixed-effects model
PH Zingmark et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2005)